Past event

Conference

Antimicrobial Resistance

Incentivizing Change towards a Global Solution

3 Oct 2013 - 00:00 to 4 Oct 2013 - 00:00

Chatham House, London

The problem of antimicrobial resistance is becoming increasingly urgent. What can be done to mitigate the spread of resistant infections, extend the effectiveness of current treatments and develop new antibiotics and vaccines to address the problem?

This conference will explore the global problem of antimicrobial resistance, outline its scale and impacts, and present ideas on what governments, health practitioners, businesses and the international community can do to deal with it.

Sessions will examine the change in policies, behaviours and incentives needed, including:

  • Strategies to overcome the problem of antimicrobial resistance worldwide
  • How resistant infections may be controlled
  • How antimicrobial resistance may be affected by the use of antibiotics in food and agriculture
  • Policies and commercial incentives needed to stimulate drug development and discovery
  • How to foster a global commitment to tackling the problem

  • Professor Preeni Abeynayake

    • Department of Veterinary Public Health and Pharmacology
  • Richard Bergström

    • Director General
  • Professor Otto Cars

    • Executive Director
  • Marco Cavaleri

    • Head of Anti-infectives and Vaccines, Safety and Efficacy Sector
  • Dr Abdul Ghafur

    • Coordinator 'Chennai Declaration' of Medical Societies in India
  • Nigel Gibbens

    • Chief Veterinary Officer
  • Martha Gyansa-Lutterodt

    • Chief Pharmacist and Director of Pharmaceutical Services
  • Professor David Heymann

    • Head and Senior Fellow
  • Professor Alison Holmes

    • Professor of Infectious Diseases
  • Professor Sir David Hopwood FRS

    • Emeritus Fellow
  • Andrew Jack

    • Pharmaceutical Correspondent
  • Dr Ramanan Laxminarayan

    • Vice President
  • Line Matthiessen

    • Head of Infectious Diseases and Public Health Unit
  • Zafar Mirza

    • Coordinator, Public Health, Innovation and Intellectual Property
  • Professor Kevin Outterson

    • Boston University
  • Dr Stephen Page

    • Advanced Veterinary Therapeutics and Honorary Associate, Faculty of Veterinary Science
  • Dr David Payne

    • Vice President, Anti-Bacterial Discovery Performance Unit
  • Dr Rosanna Peeling

    • Professor and Chair of Diagnostics Research
  • Dr Carmem Pessoa

    • Team Lead, Antimicrobial Drug Resistance
  • Professor Laura Piddock

    • Professor of Microbiology and Deputy Director Institute of Microbiology and Infection, University of Birmingham
  • Professor Didier Pittet CBE

    • Director, Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine
  • Dr Rino Rappuoli

    • Global Head of Vaccines Research
  • Dr John Rex

    • Vice President and Head of Infection, Global Medicines Development
  • Jorgen Schlundt

    • Director, National Food Institute
  • Professor Dame Sally Davies

    • Chief Medical Officer, UK
  • Dr Margaret Hamburg

    • Commissioner
  • Paul Stoffels MD

    • Chief Scientific Officer, Johnson & Johnson
  • Bernard Vallat

    • Director General
  • Patrick Vink

    • Senior Vice President and General Manager of International Business
  • Dr Liz Wagstrom

    • Chief Veterinarian Officer
  • Dr David Wallinga

    • Founder and Director of Healthy Food Action and Member, Keep Antibiotics Working

This conference will be held under the Chatham House Rule. Information for journalists
Press can request a press pass using the form below.

AstraZeneca logo

 

Gates foundation logo

 

Cubist logo

 

Dept of Health logo 


GSK logo

 

Johnson & Johnson logo

 

Novartis logo

 

BioPortfolio logo


Global Biodefense

Global Biodefense

Global Biodefense



Lancet logo


Lancet logo


Lancet logo




Pharmaphorum logo


Pharmaphorum logo


Pharmaphorum logo





Science AAAS logo


Venue

Chatham House

conferences@chathamhouse.org

Telephone: +44 (0)20 7957 5729
Fax: +44 (0)20 7957 5710


If you wish to book the venue for your event please phone +44 (0)20 7314 2764


Conference Unit
Chatham House
10 St James's Square
London
SW1Y 4LE
UK

Accommodation

Although we cannot book accommodation for delegates, we have arranged a reduced rate at some nearby hotels, where you can book your own accommodation. Please inform the hotel that you will be attending a conference at Chatham House (The Royal Institute of International Affairs) to qualify for the Institute's reduced rate.

Please note all rates are subject to availability.

Flemings Mayfair
Half Moon Street
Mayfair
London W1Y 7RA
Tel: + 44 (0)20 7499 2964
Fax: + 44 (0)20 7499 1817
Standard Single £180 + VAT

The Cavendish London
81 Jermyn Street
London
SW1U 6JF
Tel: + 44 (0)20 7930 2111
Fax: + 44 (0)20 7839 2125
Standard Single £200 + VAT

To book The Cavendish online

THURSDAY 3 OCTOBER

Session One:  Overview
09:30 - 10.50

  • What is the scale of antimicrobial resistance?

  • What are the main drivers and impacts? Why is there renewed urgency in tackling it?

  • How are countries, regions, the international community and the private sector addressing the problem?

  • What are the obstacles to achieving solutions?

Chair  
Professor David Heymann, Director, Centre on Global Health Security, Chatham House

Keynote Address
Professor Dame Sally Davies, Chief Medical Officer, UK (on the record)

Speakers     
Dr Ramanan Laxminarayan, Vice President, Public Health Foundation of India

Dr David Payne, Vice President, Anti-Bacterial Discovery Performance Unit, GlaxoSmithKline

Questions and discussion

10:50 - 11:20    Refreshments


Session Two: Maintaining Antibiotic Effectiveness and Controlling Resistant Infections
11:20 - 12:40

  • What can be done to maintain antibiotic effectiveness?

  • What particular issues do developing countries face?

  • What are the successful strategies for controlling the spread of resistant infections? How applicable are these in developing countries?

  • What are the barriers to behaviour change?

Chair
Professor Didier Pittet CBE, Director, Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine; Lead Advisor, WHO First Global Patient Safety Challenge: Clean Care is Safer Care

Speakers    
Dr Carmem Pessoa-Silva, Team Lead, World Health Organization

Professor Alison Holmes, Professor of Infectious Disease, Imperial College, London

Martha Gyansa-Lutterodt, Chief Pharmacist and Director of Pharmaceutical Services, Ministry of Health, Ghana

Dr Abdul Ghafur, Coordinator ‘Chennai Declaration’ of Medical Societies, India; Consultant, Infectious Diseases and Clinical Microbiology, Apollo Hospitals, India
Questions and discussion

12:40 - 14:00    Lunch


Session Three: Stimulating Drug development: Pipelines and Incentives
14:00 – 15:30

  • What is the nature of the shortfall in the current pipeline of new drugs?

  • How can market models for making new antibiotics be improved?

  • What new push and pull mechanisms have been tried?

  • What new approaches should be tried?


Chair
Andrew Jack, Pharmaceutical Correspondent, Financial Times

Speakers   
Dr Paul Stoffels, Chief Scientific Officer, Johnson & Johnson, Worldwide Chairman, Pharmaceuticals

Dr Line Matthiessen, Head of Infectious Diseases and Public Health Unit, DG Research and Innovation, European Commission

Professor Kevin Outterson, Associate Professor,  Boston University

Dr Marco Cavaleri, Head of Anti-infectives and Vaccines, Scientific and Regulatory Management Department, European Medicines Agency

Dr Patrick Vink, Senior Vice President and General Manager of International Business,
Cubist Pharmaceuticals

Questions and discussion

15:30 - 16:00 Refreshments

Session Four: New Approaches to Diagnosis and Discovery
16:00 - 17:20

  • What progress is there on the development of new therapeutics with novel modes of action: from phages to stimulating innate immunity?

  • How can new diagnostics aid clinical trials?

  • What can new approaches such as whole genome sequencing and genomics deliver?

  • To what extent do vaccines provide the answer in the prevention of infections caused by antimicrobial resistant bacteria?


Chair
Professor Laura Piddock, Professor of Microbiology and Deputy Director, Institute of Microbiology and Infection, University of Birmingham; BSAC Chair in Public Engagement and Director, Antibiotic Action

Speakers   
Dr Rosanna Peeling, Professor and Chair of Diagnostics Research, London School of Hygiene and Tropical Medicine

Dr John Rex, Vice President and Head of Infection, Global Medicines Development, AstraZeneca

Dr Rino Rappuoli, Global Head of Vaccines Research, Novartis Vaccines & Diagnostics

Sir David Hopwood FRS, Emeritus Fellow,  John Innes Centre

Questions and discussion

17:20  End of day one and drinks reception hosted by Chatham House



Friday 4 October 2013

Session Five: Use in Food and Agriculture: Fostering Cooperation to Address The Threat to Human and Animal Health
09:30 - 11:20

  • To what extent is the use of antibiotics in agriculture, particularly in meat and fish production, an important factor in the development of resistance in humans?

  • What are the mechanisms for the transfer of resistance to humans?

  • What has already been done to reduce the use of antibiotics in animals? How successful are global initiatives such as ‘One Health’ in encouraging medical and veterinary doctors to address the problem as a shared responsibility?

  • What new approaches should be tried?  Do vaccines provide part of the solution?

Chair
Nigel Gibbens, Chief Veterinary Officer, Department for Environment, Food and Rural Affairs, UK

Keynote Address
09:30 Dr Bernard Vallat, Director General, World Organisation for Animal Health (on the record)

Speakers
Dr Jørgen Schlundt, Director, National Food Institute, Technical University of Denmark

Professor Preeni Abeynayake, Department of Veterinary Public Health & Pharmacology, University of Peradeniya, Sri Lanka

Dr David Wallinga, Founder and Director, Healthy Food Action and Member, Keep Antibiotics Working

Dr Stephen Page, Advanced Veterinary Therapeutics and Honorary Associate, Faculty of Veterinary Science, University of Sydney

Dr Liz Wagstrom, Chief Veterinarian, National Pork Producers Council, USA

Questions and discussion

11:20 - 11:50 Refreshments

 

Session Six: Fostering Global Commitment to Combat the Problem
11:50 - 13:30

  • What can be learned from countries making the most progress? And how is this relevant to other countries?

  • How can governments, the private sector and other stakeholders work together to address this problem?

  • What can the WHO, the international community and countries do to strengthen national commitments to finding a solution?

  • Generating the political and public support for enhanced global action?


Chair
Professor Dame Sally Davies, Chief Medical Officer, UK

Keynote Address
Dr Margaret Hamburg, Commissioner, US Food and Drug Administration (on the record)

Moderated Panel Discussion

Speakers   
Professor Didier Pittet, Director, Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine; Lead Advisor, WHO First Global Patient Safety Challenge: Clean Care is Safer Care

Professor Otto Cars, Executive Director, ReAct

Dr Ramanan Laxminarayan, Vice President for Research Policy, Public Health Foundation of India

Dr Bernard Vallat, Director General, World Organisation for Animal Health
Richard Bergström, Director General, European Federation of Pharmaceutical Industries and Associations

Dr Zafar Mirza, Coordinator, Public Health, Innovation and Intellectual Property, World Health Organization

Questions and discussion

13:30  End of conference and lunch

©The Royal Institute of International Affairs 2013